These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36082864)

  • 1. Nanomedicine and Addictive Disorders: A New Approach With Cannabinoids.
    Giménez VMM; Menéndez SG; Manucha W
    Curr Pharm Des; 2022; 28(34):2795-2799. PubMed ID: 36082864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids as Potential Molecules for Addiction Disorders.
    Martín Giménez VM; Mazzei L; Sanz R; Manucha W
    Curr Protein Pept Sci; 2022; 23(3):152-157. PubMed ID: 35538819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration.
    Wang J; Ni Q; Wang Y; Zhang Y; He H; Gao D; Ma X; Liang XJ
    J Control Release; 2021 Mar; 331():282-295. PubMed ID: 32866590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid Delivery Systems for Pain and Inflammation Treatment.
    Bruni N; Della Pepa C; Oliaro-Bosso S; Pessione E; Gastaldi D; Dosio F
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30262735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanodrugs: pharmacokinetics and safety.
    Onoue S; Yamada S; Chan HK
    Int J Nanomedicine; 2014; 9():1025-37. PubMed ID: 24591825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in kidney-targeted drug delivery systems.
    Chen Z; Peng H; Zhang C
    Int J Pharm; 2020 Sep; 587():119679. PubMed ID: 32717283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Based Treatment for Cardiovascular Diseases.
    Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology.
    Mukherjee B; Dutta L; Mondal L; Dey NS; Chakraborty S; Maji R; Shaw TK
    Curr Pharm Des; 2015; 21(36):5172-86. PubMed ID: 26412361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in self-assembled nanotechnology in tumor therapy.
    Kuang Y; Li Z; Chen H; Wang X; Wen Y; Chen J
    Colloids Surf B Biointerfaces; 2024 May; 237():113838. PubMed ID: 38484445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure.
    Lin C; Gao H; Ouyang L
    J Control Release; 2021 Sep; 337():494-504. PubMed ID: 34358590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Green Synthesis and Potential Pharmaceutical Applications of Nanoparticles as Targeted Drug Delivery System in Biomedicines.
    Mittal S; Chakole CM; Sharma A; Pandey J; Chauhan MK
    Drug Res (Stuttg); 2022 Jun; 72(5):274-283. PubMed ID: 35562101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology: the scope and potential applications in orthopedic surgery.
    Gavaskar A; Rojas D; Videla F
    Eur J Orthop Surg Traumatol; 2018 Oct; 28(7):1257-1260. PubMed ID: 29602957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy.
    Tamba BI; Stanciu GD; Urîtu CM; Rezus E; Stefanescu R; Mihai CT; Luca A; Rusu-Zota G; Leon-Constantin MM; Cojocaru E; Gafton B; Alexa-Stratulat T
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The drug delivery field at the inflection point: Time to fight its way out of the egg.
    Park K
    J Control Release; 2017 Dec; 267():2-14. PubMed ID: 28754609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
    Al-Lawati H; Binkhathlan Z; Lavasanifar A
    Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.